Table 3.
Long | Short | L vs S | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | Min | Q1 | Q2 | Q3 | Max | Mean | Min | Q1 | Q2 | Q3 | Max | p ‡ | |
Questionnaires* | |||||||||||||
ACQ, Total Score | 0.66 | 0 | 0 | 0.33 | 1.00 | 2.67 | 0.74 | 0 | 0.17 | 0.50 | 1.33 | 2.83 | 0.32 |
PAIS, T-Score | 40.37 | 31.5 | 31.5 | 37.7 | 46.2 | 64.0 | 41.82 | 31.5 | 31.5 | 39.7 | 48.4 | 65.2 | 0.07 |
Spirometry (pre-albuterol) | |||||||||||||
FEV1, % pred. | 96.8 | 57.3 | 89.4 | 97.3 | 106.7 | 122.7 | 96.9 | 67.7 | 90.9 | 97.5 | 104.9 | 120.3 | 0.91 |
FVC, % pred. | 102.6 | 74.0 | 94.8 | 101.0 | 110.2 | 131.1 | 102.7 | 80.2 | 95.1 | 101.9 | 110.8 | 130.4 | 0.83 |
FEV1 / FVC ×100 | 82.7 | 61.0 | 78.0 | 84.0 | 89.0 | 98.0 | 82.9 | 56.0 | 80.0 | 85.0 | 88.0 | 94.0 | 0.73 |
eNO, ppb | 34.6 | 6.0 | 14.0 | 26.0 | 43.0 | 130.0 | 37.1 | 5.0 | 13.0 | 23.0 | 45.0 | 153.0 | 0.21 |
Cytokines† | |||||||||||||
IL-1, fg/ml | 9.3 | 0.45 | 4.0 | 5.0 | 10.4 | 63.3 | 10.0 | 0.7 | 4.1 | 6.5 | 12.0 | 56.4 | 0.52 |
IL-6, pg/ml | 0.20 | 0.05 | 0.11 | 0.18 | 0.24 | 0.67 | 0.21 | 0.03 | 0.11 | 0.14 | 0.21 | 1.30 | 0.51 |
CRP, μg/ml | 1.04 | 0.01 | 0.13 | 0.38 | 1.13 | 5.85 | 0.86 | 0.02 | 0.12 | 0.30 | 0.89 | 6.52 | 0.20 |
TNF-alpha, pg/ml | 1.58 | 0.8 | 1.3 | 1.5 | 1.8 | 2.6 | 1.59 | 0.9 | 1.3 | 1.6 | 1.8 | 2.7 | 0.69 |
ACQ: Asthma Control Questionnaire; PAIS: PROMIS Asthma Impact Scale
fg: femtograms; pg: picograms; μg: micrograms
Based on paired t-tests; for right-skewed cytokine variables (IL-1, IL-6, CRP) paired t-tests were performed on differences of natural-logged variables.